Mini Kamboj
About
Mini Kamboj is a scholar working on Infectious Diseases, Epidemiology and Oncology.
According to data from OpenAlex, Mini Kamboj has authored 127 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Infectious Diseases, 58 papers in Epidemiology and 41 papers in Oncology. Recurrent topics in Mini Kamboj's work include Clostridium difficile and Clostridium perfringens research (28 papers), Viral gastroenteritis research and epidemiology (24 papers) and COVID-19 and healthcare impacts (22 papers). Mini Kamboj is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (28 papers), Viral gastroenteritis research and epidemiology (24 papers) and COVID-19 and healthcare impacts (22 papers). Mini Kamboj collaborates with scholars based in United States, China and Canada. Mini Kamboj's co-authors include Kent A. Sepkowitz, N. Esther Babady, Eric G. Pamer, Marcel R.M. van den Brink, Ying Taur, K. A. Sepkowitz, Agnès Viale, Robert R. Jenq, Michele Equinda and Carles Úbeda and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Investigation.
In The Last Decade
Mini Kamboj
117 papers receiving 3.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Mini Kamboj United States | 30 | 2.1k | 1.2k | 794 | 649 | 384 | 127 | 3.4k | ||
| George Alangaden United States | 34 | 2.5k 1.2× | 2.2k 1.8× | 526 0.7× | 426 0.7× | 431 1.1× | 129 | 4.3k | ||
| Michael J. Satlin United States | 35 | 1.0k 0.5× | 1.3k 1.1× | 598 0.8× | 614 0.9× | 151 0.4× | 116 | 4.0k | ||
| Leon J. Worth Australia | 35 | 1.1k 0.5× | 1.4k 1.2× | 769 1.0× | 220 0.3× | 430 1.1× | 155 | 3.4k | ||
| Mario Cruciani Italy | 39 | 2.4k 1.1× | 1.9k 1.6× | 486 0.6× | 282 0.4× | 623 1.6× | 156 | 4.7k | ||
| Natividad Benito Spain | 34 | 1.4k 0.7× | 1.9k 1.5× | 356 0.4× | 798 1.2× | 782 2.0× | 116 | 4.1k | ||
| Fernanda P. Silveira United States | 36 | 1.6k 0.8× | 2.9k 2.4× | 515 0.6× | 256 0.4× | 582 1.5× | 96 | 4.7k | ||
| June Myung Kim South Korea | 32 | 876 0.4× | 1.2k 1.0× | 373 0.5× | 438 0.7× | 546 1.4× | 202 | 3.6k | ||
| Roberto Luzzati Italy | 33 | 1.9k 0.9× | 1.5k 1.2× | 229 0.3× | 470 0.7× | 478 1.2× | 158 | 3.9k | ||
| Dionysios Neofytos Switzerland | 30 | 3.4k 1.7× | 3.2k 2.6× | 579 0.7× | 296 0.5× | 237 0.6× | 120 | 4.5k | ||
| Giuliano Rizzardini Italy | 34 | 2.5k 1.2× | 1.2k 1.0× | 478 0.6× | 613 0.9× | 243 0.6× | 192 | 4.7k |
Countries citing papers authored by Mini Kamboj
Since
Specialization
Citations
This map shows the geographic impact of Mini Kamboj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mini Kamboj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mini Kamboj more than expected).
Fields of papers citing papers by Mini Kamboj
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Mini Kamboj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mini Kamboj. The network helps show where Mini Kamboj may publish in the future.
Co-authorship network of co-authors of Mini Kamboj
This figure shows the co-authorship network connecting the top 25 collaborators of Mini Kamboj. A scholar is included among the top collaborators of Mini Kamboj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mini Kamboj. Mini Kamboj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Ruppel, Hans Georg, Evan S. Snitkin, Vincent B. Young, et al.. (2025). Flagellar switch inverted repeats impact heterogeneity in flagellar gene expression and thus C. difficile RT027/MLST1 virulence. Cell Reports. 44(6). 115830–115830.
2.
Laracy, Justin, June L. Chan, Kevin Raible, et al.. (2025). Improving Urinary Tract Infection Diagnostics in Oncology: Reliability of Reflex Urine Culture in Immunosuppressed Neutropenic and Non-neutropenic Cancer Patients. Clinical Infectious Diseases. 80(5). 969–974.
3.
Asturias, Edwin J., Lin H. Chen, Albert C. Shaw, et al.. (2025). Science for vaccine policy: Independent review of the September 2025 ACIP processes, deliberations and votes. Vaccine. 67. 127876–127876.
4.
Kobayashi, Miwako, Andrew J. Leidner, Ryan Gierke, et al.. (2025). Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024. MMWR Morbidity and Mortality Weekly Report. 74(1). 1–8.
5.
Aslam, Anoshé, et al.. (2024). Impact of universal masking in reducing the risk of nosocomial respiratory viruses among people with cancer. Infection Control and Hospital Epidemiology. 45(12). 1405–1409.
6.
Kamboj, Mini, Kari Bohlke, Kieron Dunleavy, et al.. (2024). Vaccination of Adults With Cancer: ASCO Guideline. Journal of Clinical Oncology. 42(14). 1699–1721.
7.
Laracy, Justin, Nina Cohen, Elizabeth Robilotti, et al.. (2023). Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients. Haematologica. 108(11). 3058–3067.
8.
Shah, Gunjan L., David J. Chung, Roni Tamari, et al.. (2022). Humoral Response to COVID-19 Vaccination Given Pre-Cellular Therapy Wanes in Patients after Cellular Therapy: An Argument for Full Reimmunization. Transplantation and Cellular Therapy. 28(3). S373–S374.
9.
Khawaja, Fareed, Genovefa A. Papanicolaou, Sanjeet Dadwal, et al.. (2022). Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology. Transplantation and Cellular Therapy. 29(1). 10–18.
10.
Laracy, Justin, Elizabeth Robilotti, Anabella Lucca Bianchi, et al.. (2022). Comparison of coronavirus disease 2019 (COVID-19) symptoms at diagnosis among healthcare personnel before and after the emergence of the omicron variant. Infection Control and Hospital Epidemiology. 44(5). 821–823.
11.
DeWolf, Susan, Justin Laracy, Miguel‐Angel Perales, et al.. (2022). SARS-CoV-2 in immunocompromised individuals. Immunity. 55(10). 1779–1798.
12.
Tamari, Roni, Ioannis Politikos, David A. Knorr, et al.. (2021). Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy. Blood Cancer Discovery. 2(6). 577–585.
13.
Young, Vincent B., Eric G. Pamer, Tor Savidge, et al.. (2021). A multisite genomic epidemiology study of Clostridioides difficile infections in the USA supports differential roles of healthcare versus community spread for two common strains. Microbial Genomics. 7(6).
14.
Shah, Nishi, Parastoo B. Dahi, Doris M. Ponce, et al.. (2021). Hematopoietic Cell Transplantation is Feasible in Patients with Prior COVID-19 Infection. Transplantation and Cellular Therapy. 28(1). 55.e1–55.e5.
15.
Pergam, Steven A., Janet A. Englund, Mini Kamboj, et al.. (2019). Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation. 25(11). e321–e330.
16.
Robilotti, Elizabeth, et al.. (2019). Viral oncolytic immunotherapy in the war on cancer: Infection control considerations. Infection Control and Hospital Epidemiology. 40(3). 350–354.
17.
McMillen, Tracy, Yuanyuan Qiu, Xuedong Lu, et al.. (2017). Norovirus Loads in Stool Specimens of Cancer Patients with Norovirus Gastroenteritis. Journal of Molecular Diagnostics. 19(6). 836–842.
18.
Kaltsas, Anna, Danielle Wroblewski, Kimberlee A. Musser, et al.. (2012). Clinical and Laboratory Characteristics of Clostridium difficile Infection in Patients with Discordant Diagnostic Test Results. Journal of Clinical Microbiology. 50(4). 1303–1307.
19.
Guleria, Sandeep, Mini Kamboj, Prabhjot Singh, et al.. (2006). Tacrolimus (Pan Graf) as de Novo Therapy in Renal Transplant Recpients in India. Transplantation Proceedings. 38(7). 2029–2031.
20.
Kamboj, Mini & K. A. Sepkowitz. (2006). The Risk of Tuberculosis in Patients with Cancer. Clinical Infectious Diseases. 42(11). 1592–1595.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by George Alangaden Breakdown of academic impact, for papers by Michael J. Satlin Breakdown of academic impact, for papers by Leon J. Worth Breakdown of academic impact, for papers by Mario Cruciani Breakdown of academic impact, for papers by Natividad Benito Breakdown of academic impact, for papers by Fernanda P. Silveira Breakdown of academic impact, for papers by June Myung Kim Breakdown of academic impact, for papers by Roberto Luzzati Breakdown of academic impact, for papers by Dionysios Neofytos Breakdown of academic impact, for papers by Giuliano Rizzardini